No black box warning on record for Ryaltris
As of the latest FDA labeling reviewed, Ryaltris (OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Ryaltris medicine page for the complete safety profile.